|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 209.45 GBX | -0.26% |
|
-1.20% | +0.70% |
| 09/03 | Hutchmed (China) says Ipsen initiates market withdrawal and recall of Tazverik in China | RE |
| 09/03 | Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB… |  |
Company Valuation: HUTCHMED (China) Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 6,146 | 2,688 | 3,076 | 2,514 | 2,406 | 2,390 | - | - |
| Change | - | -56.27% | 14.44% | -18.26% | -4.31% | -0.67% | - | - |
| Enterprise Value (EV) 1 | 5,162 | 2,075 | 2,872 | 2,443 | 2,406 | 1,732 | 1,749 | 1,488 |
| Change | - | -59.8% | 38.4% | -14.93% | -1.52% | -28.04% | 1% | -14.94% |
| P/E ratio | -28.7x | -7.4x | 30x | 73.6x | 5.38x | 46.8x | 41.4x | 37x |
| PBR | 6.29x | 4.51x | 4.29x | 3.37x | - | 1.57x | 1.5x | 1.41x |
| PEG | - | -0.1x | -0x | -1.1x | 0x | -0.5x | 3.2x | 3.1x |
| Capitalization / Revenue | 17.3x | 6.3x | 3.67x | 3.99x | 4.39x | 3.7x | 3.21x | 2.87x |
| EV / Revenue | 14.5x | 4.87x | 3.43x | 3.88x | 4.39x | 2.68x | 2.35x | 1.79x |
| EV / EBITDA | -16.1x | -5.2x | 108x | -77.9x | - | -902x | 55.1x | 26.9x |
| EV / EBIT | -15.7x | -5.09x | 156x | -55.9x | -61.4x | -147x | 74.1x | 30.7x |
| EV / FCF | -23.4x | -6.8x | 15.4x | -140x | - | 118x | 56.8x | 29x |
| FCF Yield | -4.27% | -14.7% | 6.5% | -0.71% | - | 0.85% | 1.76% | 3.45% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.25 | -0.43 | 0.12 | 0.04 | 0.52 | 0.0594 | 0.0671 | 0.0751 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 356.1 | 426.4 | 838 | 630.2 | 548.5 | 646.8 | 745.1 | 832.2 |
| EBITDA 1 | -321.1 | -399 | 26.58 | -31.36 | - | -1.92 | 31.72 | 55.39 |
| EBIT 1 | -328.3 | -407.7 | 18.38 | -43.7 | -39.16 | -11.75 | 23.61 | 48.45 |
| Net income 1 | -194.6 | -360.8 | 100.8 | 37.73 | 456.9 | 40.85 | 67.4 | 92.68 |
| Net Debt 1 | -984.8 | -612.9 | -204.2 | -71.15 | - | -658.4 | -641.1 | -902.4 |
| Reference price 2 | 7.177 | 3.181 | 3.605 | 2.942 | 2.799 | 2.780 | 2.780 | 2.780 |
| Nbr of stocks (in thousands) | 8,56,470 | 8,45,074 | 8,53,410 | 8,54,681 | 8,59,517 | 8,59,744 | - | - |
| Announcement Date | 03/03/22 | 28/02/23 | 28/02/24 | 19/03/25 | 05/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 46.82x | 2.66x | -901.75x | -.--% | 238.99Cr | |
| 28.95x | 10.91x | 21.91x | 0.67% | 88TCr | |
| 25.63x | 5.96x | 16.23x | 2.19% | 58TCr | |
| 24x | 6.55x | 13.15x | 3.16% | 39TCr | |
| 17.32x | 4.22x | 10.43x | 3.13% | 32TCr | |
| 23.94x | 4.98x | 13.83x | 1.75% | 30TCr | |
| 20.93x | 5.64x | 13.96x | 2.87% | 29TCr | |
| 27.02x | 4.74x | 14.82x | 2.92% | 29TCr | |
| 24.64x | 6.26x | 11.14x | 2.74% | 20TCr | |
| 20.1x | 6.12x | 11.06x | 2.25% | 18TCr | |
| Average | 25.93x | 5.80x | -77.52x | 2.17% | 34.29TCr | |
| Weighted average by Cap. | 24.75x | 6.94x | 15.07x | 2.11% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- HCM Stock
- Valuation HUTCHMED (China) Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition